NanoEntek, Inc. (KOSDAQ:039860)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,540.00
+140.00 (3.18%)
At close: Jun 12, 2026
Market Cap172.94B +59.8%
Revenue (ttm)40.66B +27.7%
Net Income2.65B -21.9%
EPS75.62 -30.4%
Shares Out 38.09M
PE Ratio60.03
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume212,458
Open4,490.00
Previous Close4,400.00
Day's Range4,420.00 - 4,605.00
52-Week Range3,015.00 - 9,390.00
Beta0.69
Analystsn/a
Price Target3,600.00 (-20.7%)
Earnings DateAug 14, 2026

About NanoEntek

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic... [Read more]

Industry Laboratory Analytical Instruments
Founded 1987
Employees 97
Stock Exchange KOSDAQ
Ticker Symbol 039860
Full Company Profile

Financial Performance

In 2025, NanoEntek's revenue was 38.13 billion, an increase of 25.16% compared to the previous year's 30.46 billion. Earnings were 1.58 billion, a decrease of -55.93%.

Financial Statements